Radiopharmaceutical-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data

Publisher Name :
Date: 01-Aug-2019
No. of pages: 134

Report Summary

Radiopharmaceutical-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data offers a comprehensive analysis on Radiopharmaceutical industry, standing on the readers' perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Radiopharmaceutical 2014-2019, and development forecast 2020-2026

Main manufacturers/suppliers of Radiopharmaceutical worldwide and market share by regions, with company and product introduction, position in the Radiopharmaceutical market

Market status and development trend of Radiopharmaceutical by types and applications

Cost and profit status of Radiopharmaceutical, and marketing status

Market growth drivers and challenges

The report segments the global Radiopharmaceutical market as:

Global Radiopharmaceutical Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2014-2026):

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)

Asia Pacific (China, Japan, India, Southeast Asia and Australia)

Latin America (Brazil, Argentina and Colombia)

Middle East and Africa

Global Radiopharmaceutical Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2014-2026):

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Global Radiopharmaceutical Market: Application Segment Analysis (Consumption Volume and Market Share 2014-2026; Downstream Customers and Market Analysis)

Oncology

Cardiology

Other

Global Radiopharmaceutical Market: Manufacturers Segment Analysis (Company and Product introduction, Radiopharmaceutical Sales Volume, Revenue, Price and Gross Margin):

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Radiopharmaceutical-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data

Table of Contents

Chapter 1 Overview of Radiopharmaceutical
1.1 Definition of Radiopharmaceutical in This Report
1.2 Commercial Types of Radiopharmaceutical
1.2.1 Actinium-225
1.2.2 Lutetium-177
1.2.3 Radium-223
1.2.4 Holmium-166
1.2.5 Other
1.3 Downstream Application of Radiopharmaceutical
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Development History of Radiopharmaceutical
1.5 Market Status and Trend of Radiopharmaceutical 2014-2026
1.5.1 Global Radiopharmaceutical Market Status and Trend 2014-2026
1.5.2 Regional Radiopharmaceutical Market Status and Trend 2014-2026

Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Radiopharmaceutical 2014-2019
2.2 Sales Market of Radiopharmaceutical by Regions
2.2.1 Sales Volume of Radiopharmaceutical by Regions
2.2.2 Sales Value of Radiopharmaceutical by Regions
2.3 Production Market of Radiopharmaceutical by Regions
2.4 Global Market Forecast of Radiopharmaceutical 2020-2026
2.4.1 Global Market Forecast of Radiopharmaceutical 2020-2026
2.4.2 Market Forecast of Radiopharmaceutical by Regions 2020-2026

Chapter 3 Global Market Status and Forecast by Types
3.1 Sales Volume of Radiopharmaceutical by Types
3.2 Sales Value of Radiopharmaceutical by Types
3.3 Market Forecast of Radiopharmaceutical by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Global Sales Volume of Radiopharmaceutical by Downstream Industry
4.2 Global Market Forecast of Radiopharmaceutical by Downstream Industry

Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
5.1 North America Radiopharmaceutical Market Status by Countries
5.1.1 North America Radiopharmaceutical Sales by Countries (2014-2019)
5.1.2 North America Radiopharmaceutical Revenue by Countries (2014-2019)
5.1.3 United States Radiopharmaceutical Market Status (2014-2019)
5.1.4 Canada Radiopharmaceutical Market Status (2014-2019)
5.1.5 Mexico Radiopharmaceutical Market Status (2014-2019)
5.2 North America Radiopharmaceutical Market Status by Manufacturers
5.3 North America Radiopharmaceutical Market Status by Type (2014-2019)
5.3.1 North America Radiopharmaceutical Sales by Type (2014-2019)
5.3.2 North America Radiopharmaceutical Revenue by Type (2014-2019)
5.4 North America Radiopharmaceutical Market Status by Downstream Industry (2014-2019)

Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
6.1 Europe Radiopharmaceutical Market Status by Countries
6.1.1 Europe Radiopharmaceutical Sales by Countries (2014-2019)
6.1.2 Europe Radiopharmaceutical Revenue by Countries (2014-2019)
6.1.3 Germany Radiopharmaceutical Market Status (2014-2019)
6.1.4 UK Radiopharmaceutical Market Status (2014-2019)
6.1.5 France Radiopharmaceutical Market Status (2014-2019)
6.1.6 Italy Radiopharmaceutical Market Status (2014-2019)
6.1.7 Russia Radiopharmaceutical Market Status (2014-2019)
6.1.8 Spain Radiopharmaceutical Market Status (2014-2019)
6.1.9 Benelux Radiopharmaceutical Market Status (2014-2019)
6.2 Europe Radiopharmaceutical Market Status by Manufacturers
6.3 Europe Radiopharmaceutical Market Status by Type (2014-2019)
6.3.1 Europe Radiopharmaceutical Sales by Type (2014-2019)
6.3.2 Europe Radiopharmaceutical Revenue by Type (2014-2019)
6.4 Europe Radiopharmaceutical Market Status by Downstream Industry (2014-2019)

Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
7.1 Asia Pacific Radiopharmaceutical Market Status by Countries
7.1.1 Asia Pacific Radiopharmaceutical Sales by Countries (2014-2019)
7.1.2 Asia Pacific Radiopharmaceutical Revenue by Countries (2014-2019)
7.1.3 China Radiopharmaceutical Market Status (2014-2019)
7.1.4 Japan Radiopharmaceutical Market Status (2014-2019)
7.1.5 India Radiopharmaceutical Market Status (2014-2019)
7.1.6 Southeast Asia Radiopharmaceutical Market Status (2014-2019)
7.1.7 Australia Radiopharmaceutical Market Status (2014-2019)
7.2 Asia Pacific Radiopharmaceutical Market Status by Manufacturers
7.3 Asia Pacific Radiopharmaceutical Market Status by Type (2014-2019)
7.3.1 Asia Pacific Radiopharmaceutical Sales by Type (2014-2019)
7.3.2 Asia Pacific Radiopharmaceutical Revenue by Type (2014-2019)
7.4 Asia Pacific Radiopharmaceutical Market Status by Downstream Industry (2014-2019)

Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
8.1 Latin America Radiopharmaceutical Market Status by Countries
8.1.1 Latin America Radiopharmaceutical Sales by Countries (2014-2019)
8.1.2 Latin America Radiopharmaceutical Revenue by Countries (2014-2019)
8.1.3 Brazil Radiopharmaceutical Market Status (2014-2019)
8.1.4 Argentina Radiopharmaceutical Market Status (2014-2019)
8.1.5 Colombia Radiopharmaceutical Market Status (2014-2019)
8.2 Latin America Radiopharmaceutical Market Status by Manufacturers
8.3 Latin America Radiopharmaceutical Market Status by Type (2014-2019)
8.3.1 Latin America Radiopharmaceutical Sales by Type (2014-2019)
8.3.2 Latin America Radiopharmaceutical Revenue by Type (2014-2019)
8.4 Latin America Radiopharmaceutical Market Status by Downstream Industry (2014-2019)

Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
9.1 Middle East and Africa Radiopharmaceutical Market Status by Countries
9.1.1 Middle East and Africa Radiopharmaceutical Sales by Countries (2014-2019)
9.1.2 Middle East and Africa Radiopharmaceutical Revenue by Countries (2014-2019)
9.1.3 Middle East Radiopharmaceutical Market Status (2014-2019)
9.1.4 Africa Radiopharmaceutical Market Status (2014-2019)
9.2 Middle East and Africa Radiopharmaceutical Market Status by Manufacturers
9.3 Middle East and Africa Radiopharmaceutical Market Status by Type (2014-2019)
9.3.1 Middle East and Africa Radiopharmaceutical Sales by Type (2014-2019)
9.3.2 Middle East and Africa Radiopharmaceutical Revenue by Type (2014-2019)
9.4 Middle East and Africa Radiopharmaceutical Market Status by Downstream Industry (2014-2019)

Chapter 10 Market Driving Factor Analysis of Radiopharmaceutical
10.1 Global Economy Situation and Trend Overview
10.2 Radiopharmaceutical Downstream Industry Situation and Trend Overview

Chapter 11 Radiopharmaceutical Market Competition Status by Major Manufacturers
11.1 Production Volume of Radiopharmaceutical by Major Manufacturers
11.2 Production Value of Radiopharmaceutical by Major Manufacturers
11.3 Basic Information of Radiopharmaceutical by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Radiopharmaceutical Major Manufacturer
11.3.2 Employees and Revenue Level of Radiopharmaceutical Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch

Chapter 12 Radiopharmaceutical Major Manufacturers Introduction and Market Data
12.1 Bracco Imaging
12.1.1 Company profile
12.1.2 Representative Radiopharmaceutical Product
12.1.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Bracco Imaging
12.2 Bayer
12.2.1 Company profile
12.2.2 Representative Radiopharmaceutical Product
12.2.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Bayer
12.3 Mallinckrodt
12.3.1 Company profile
12.3.2 Representative Radiopharmaceutical Product
12.3.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Mallinckrodt
12.4 Nordion
12.4.1 Company profile
12.4.2 Representative Radiopharmaceutical Product
12.4.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Nordion
12.5 Triad Isotopes
12.5.1 Company profile
12.5.2 Representative Radiopharmaceutical Product
12.5.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Triad Isotopes
12.6 Lantheus
12.6.1 Company profile
12.6.2 Representative Radiopharmaceutical Product
12.6.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Lantheus
12.7 IBA Group
12.7.1 Company profile
12.7.2 Representative Radiopharmaceutical Product
12.7.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of IBA Group
12.8 GE Healthcare
12.8.1 Company profile
12.8.2 Representative Radiopharmaceutical Product
12.8.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of GE Healthcare
12.9 China Isotope & Radiation
12.9.1 Company profile
12.9.2 Representative Radiopharmaceutical Product
12.9.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of China Isotope & Radiation
12.10 Jubilant Pharma
12.10.1 Company profile
12.10.2 Representative Radiopharmaceutical Product
12.10.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Jubilant Pharma
12.11 Eli Lilly
12.11.1 Company profile
12.11.2 Representative Radiopharmaceutical Product
12.11.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Eli Lilly
12.12 Advanced Accelerator Applications
12.12.1 Company profile
12.12.2 Representative Radiopharmaceutical Product
12.12.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications
12.13 SIEMENS
12.13.1 Company profile
12.13.2 Representative Radiopharmaceutical Product
12.13.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of SIEMENS
12.14 Dongcheng
12.14.1 Company profile
12.14.2 Representative Radiopharmaceutical Product
12.14.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Dongcheng
12.15 Navidea
12.15.1 Company profile
12.15.2 Representative Radiopharmaceutical Product
12.15.3 Radiopharmaceutical Sales, Revenue, Price and Gross Margin of Navidea

Chapter 13 Upstream and Downstream Market Analysis of Radiopharmaceutical
13.1 Industry Chain of Radiopharmaceutical
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

Chapter 14 Cost and Gross Margin Analysis of Radiopharmaceutical
14.1 Cost Structure Analysis of Radiopharmaceutical
14.2 Raw Materials Cost Analysis of Radiopharmaceutical
14.3 Labor Cost Analysis of Radiopharmaceutical
14.4 Manufacturing Expenses Analysis of Radiopharmaceutical

Chapter 15 Report Conclusion

Chapter 16 Research Methodology and Reference
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
  • Global Radiopharmaceutical Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......
  • Global Radiopharmaceuticals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......
  • Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137
    According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......
  • Global Radiation Dose Management Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......
  • Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......
  • Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
  • Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs